Featured News
![](/sites/default/files/styles/4_3_medium/public/2024/07/03/aim-07-0456.jpg?itok=BZumbNaD)
AIM Blog
Recognizing AIM’s July Advocate of the Month: Molina Gonzales
Each month, we’re featuring an advocate who engages with policymakers to ensure priorities that improve the lives of people impacted by Alzheimer’s and all other dementia remain top-of-mind in Congres...
All News
![Appropriations and Research](/sites/default/files/styles/4_3_small/public/2022/06/14/image%2059.png?itok=pzhcBO-0)
Press Release
Alzheimer’s Association, Individuals Living with Alzheimer’s Urge FDA to Grant Traditional Approval for Lecanemab
CHICAGO, May 25, 2023 — The Alzheimer's Association and members of the Association's Early Stage Advisory Group submitted comments to...
Press Release
Alzheimer’s Advocate Testifies What Access to FDA-Approved Alzheimer’s Treatments Means
— Congressional Bipartisan Support for Individuals, Families and Treatment on Display — WASHINGTON, D.C., May 10, 2023 — Today, Tony...
![Scientist at Microscope](/sites/default/files/styles/4_3_small/public/2022/12/20/Scientist-Using-Microscope-in-Laboratory-909176662_7360x4912%20%283%29_0.jpeg?itok=L4AC7J1K)
Press Release
Alzheimer’s Association Statement on Donanemab Phase 3 Topline Data Release
Strongest Alzheimer's Phase 3 data release to date Association underscores urgent call for CMS to stop blocking access to FDA-approved...
![Priya at capitol](/sites/default/files/styles/4_3_small/public/2023/04/25/Image.jpeg?itok=ZmEWm149)
AIM Blog
Recognizing AIM’s May Advocate of the Month: Priya Patel
Each month, we’re featuring an advocate who engages with policymakers to ensure priorities that improve the lives of people impacted...
![E&C hearing advocates](/sites/default/files/styles/4_3_small/public/2023/04/26/HearingAdvocates.jpg?itok=iuY2MykK)
Press Release
Overwhelming Bipartisan Support for Access to FDA-Approved Alzheimer’s Treatments on Display in Health Subcommittee Hearing
Bipartisan members sharply question CMS Administrator why Alzheimer’s drugs aren’t reasonable and necessary Washington, D.C., April 26, 2023 — Today...
![petition graphic](/sites/default/files/styles/4_3_small/public/2023/04/21/ALZ_CMS%20Petition_1280x720_April%2021%202023%5B95%5D.png?itok=DRgos3tj)
AIM Blog
Sign the Petition: Urge President Biden to Tell CMS to Stop Blocking Access to Alzheimer’s Treatments
For over a year, the Centers for Medicare & Medicaid Services (CMS) has been blocking access to Food and Drug...